“⚙r대전둔산동룸바r☎O1O.8001.8445 r대전룸싸롱r월평동가라오케r대전유흥주점r괴정동가라오케r유성룸싸롱r유성풀싸롱r유성유흥주점r대전동구룸바r대흥동노래방r⚙”的搜索结果，显示 11-20 项，共有 7874 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus MabThera ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R FL), who have completed at least 1 prior systemic chemotherapy, immunotherapy, or chemoimmunotherapy. Two Studies for Patients With High Risk ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international ... (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). Cholecalciferol in ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R FL), who have completed at least 1 prior systemic chemotherapy, immunotherapy, or chemoimmunotherapy. Two Studies for Patients With High Risk ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R FL), who have completed at least 1 prior systemic chemotherapy, immunotherapy, or chemoimmunotherapy. Two Studies for Patients With High Risk ...

7. 患者就诊及探视者最新信息：罗切斯特院区- 妙佑医疗国际

   妙佑医疗国际明尼苏达州罗切斯特院区提供安全的直接护理，并制定了防止COVID-19 传播的方案。

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel ...

10. 乳腺专科门诊- 临床试验- 妙佑医疗国际

    This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal ...